… therapeutic approach. Recent research focus in the regime … cancer therapy involves the
engagement of targeted delivery of siRNA/miRNA in combinations with other therapeutic agents (…

… for stabilizing binding conditions, restrictions on permitted target sequences and inefficient
nuclear delivery of oligonucleotides before they can become mainstream for cancer therapy. …

… Therefore, combination therapy with two or more therapeutic agents is being arisen. One of
… of cancer therapy, we will evaluate combining a variety of anticancer drugs and siRNA with …

… of siRNA, increasing their halflife in blood. ► Treatment using co-delivery systems, rather
than co-treatment, of drugs and siRNA is more effective in overcoming resistance of cancer …

… list of diseases for which siRNA is being tested as a therapeutic agent is extensive. Although
… or utilising single siRNA in conjunction with other therapeutic agents. For example, three …

… small molecule therapeutics simultaneously with siRNA can enhance … siRNA is also a
promising therapeutic agent against a variety of other diseases. siRNA is attractive for therapeutic …

… Since the outer surface of AuNPs is the only assessable space for loading, the most
straightforward strategy for co-delivery is to load both of the siRNA and the other therapeutic agent …

… siRNA in the same NP would be much more effective in cancer therapy than application of
chemical agent or siRNA … -deliver therapeutic agents and siRNAs for cancer therapy and have …

… of targeted delivery of small interfering RNA (siRNA) to the lungs must be developed. … in
siRNA delivery to airway cells in vitro and the work to date on in vivo delivery of siRNA to the …

… therapeutic agents/small interfering RNA (siRNA) as a potent gene-editing tool in cancer
therapy … In the present review, co-delivery of natural compounds/siRNA using nanovehicles are …